Several Chinese nationals, including two scientists who worked for GlaxoSmithKline, charged with stealing cancer medication trade secrets from the drugmaker are set to stand trial next year.

U.S. District Judge Joel H. Slomsky of the Eastern District of Pennsylvania slated Oct. 22, 2018, as the trial date for the accused.

Following an FBI investigation, Yu Xue, 46, of Wayne; Tao Li, 43, of Nanjing, China; Yan Mei, 37, of Nanjing; Tian Xue, 46, of Charlotte, North Carolina; and Lucy Xi, 39, of Westlake Village, California, were indicted in January 2016 on charges of conspiracy to steal trade secrets, conspiracy to commit wire fraud, conspiracy to commit money laundering, theft of trade secrets, and wire fraud. If convicted, the defendants face possible prison time and fines.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Go To Lexis →

Not a Lexis Subscriber?
Subscribe Now

Go To Bloomberg Law →

Not a Bloomberg Law Subscriber?
Subscribe Now

NOT FOR REPRINT